Toggle Health Problems and D

Iran Multiple Sclerosis review finds huge increase in women (no mention of clothing) – Nov 2013

Epidemiology of Multiple Sclerosis in Iran: A Systematic Review

Etemadifar M.a, b · Sajjadi S.b, c · Nasr Z.b, c · Firoozeei T.S.b · Abtahi S.-H.b, c · Akbari M.d · Fereidan-Esfahani M.b,c,e
A Department of Neurology, Medical School, b Isfahan Research Committee of Multiple Sclerosis (IRCOMS), c Medical Students' Research Committee, d Department of Epidemiology and Statistics, Isfahan University of Medical Science, and e Persia Research Center, Sady Hospital, Isfahan, Iran
email Corresponding Author

Background: There is a wide variation in the prevalence of multiple sclerosis (MS) in different geographical regions and the epidemiology of MS in Iran has been a major topic of concern during the last decade. Several population-based studies have shown a sharp increase in the prevalence and incidence of MS in this region. In this study, for the first time, the aim was to provide a comprehensive review regarding the incidence and prevalence of MS across Iran.

Methods: A comprehensive literature search was performed using PubMed, Embase, and Web of Science. We also did a manual search of reference lists from primary articles and relevant reviews. Databases of ongoing research and unpublished literature were also searched.

Results: A total of 22 relevant studies were reviewed and 11 studies met the inclusion criteria. Incidence data were found in 5 studies and ranged from 0.68 to 9.1/100,000 per year in the Iranian population. Prevalence was reported in all studies and ranged from 5.3 to 74.28/100,000 with the higher prevalence among females (female/male ratio ranged from 1.8 to 3.6). The most prevalent subtype of MS was the relapsing-remitting form (65.8-87.8%). The sensory disturbance was the most initial presentation.

Conclusion: The incidence and prevalence of MS in Iran has been increasing rapidly, especially in females. Future research should focus on determining the epidemiological features of MS in the neglected provinces with different ethnicities. Such an effort along with further research towards improvement of data on previously studied areas can enable a field to be opened up to identify the patterns of MS in varied genetic backgrounds and environments of Iran.

© 2013 S. Karger AG, Basel

PDF is attached at the bottom of this page

How can they claim that the F/M ratio ranges only from 1.8 – 3.6
Look at the data: F/M ratios in red added by VitaminDWiki

See also VitaminDWiki

Summary: lack of consensus on how much to prevent, treat, or cure MS.

  • How much Vitamin D to prevent many diseases - such as MS
  • How much Vitamin D is needed to treat MS? There is currently no agreement
       The recommendations range from 40 to 100 ng - which can result of a dose ranging from 3,000 to 20,000 IU/day
  • How Vitamin D is needed to Cure MS?: It appears that 20,000-140,000 IU daily may be needed to CURE the disease
       You must be under the supervision of a doctor who knows what to watch for in your individual situation.
       High doses of Vitamin D cannot be used as a monotherapy.
       You will need to adjust the cofactors: Typically increasing Magnesium and Vitamin K2, and reducing Calcium intake.
       Your doctor will monitor these and might increase your intake of Vitamins B2, C, as well as Omega-3

Dress codes in the Middle East - strongly enforced in cities in Iran

from Wikipedia Nov 2013

Attached files

ID Name Comment Uploaded Size Downloads
3222 MS Iran.jpg admin 09 Nov, 2013 01:27 92.85 Kb 1700
3221 Iran MS.pdf PDF - 2013 admin 09 Nov, 2013 01:27 170.51 Kb 1475
See any problem with this page? Report it (FINALLY WORKS)